Veterinary Surgical Oncology. Группа авторов
Development of an allogeneic whole‐cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma. Cancer Immunol Immunother 55:433–442.
11 Allstadt, S.D., C.O. RodriguezJr., B. Boostrom, et al. 2015. Randomized phase Iii trial of piroxicam in combination with mitoxantrone or carboplatin for first‐line treatment of urogenital tract transitional cell carcinoma in dogs. J Vet Intern Med 29:261–267.
12 AL‐Sarraf, R., G.N. Mauldin, A.K. Patnaik, et al. 1996. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. J Vet Intern Med 10:376–378.
13 Alvarez, F.J., W. Kisseberth, K. Hosoya, et al. 2014. Postoperative adjuvant combination therapy with doxorubicin and noncytotoxic suramin in dogs with appendicular osteosarcoma. J Am Anim Hosp Assoc 50:12–18.
14 Alwen, S.G., W.T. Culp, A. Szivek, et al. 2015. Portal site metastasis after thoracoscopic resection of a cranial mediastinal mass in a dog. J Am Vet Med Assoc 247:793–800.
15 Amores‐Fuster, I., P. Cripps, and L. Blackwood. 2017. Post‐radiotherapy hypothyroidism in dogs treated for thyroid carcinomas. Vet Comp Oncol 15(1):247–251.
16 Amsellem, P.M., L.E. Selmic, J.M. Wypij, et al. 2014. Appendicular osteosarcoma in small‐breed dogs: 51 cases (1986–2011). J Am Vet Med Assoc 245:203–210.
17 Anderson, C. and K. Pratschke. 2011. Uterine adenocarcinoma with abdominal metastases in an ovariohysterectomised cat. J Feline Med Surg 13:44–47.
18 Argyle, D.J., C.A. London, A.J. Mutsaers, et al. 2013. 14 – Molecular/targeted therapy of cancer. In Withrow and MacEwen's Small Animal Clinical Oncology, 5th edition. R.L. Page, S.J. Withrow, and D.M. Vail, editors. St. Louis: W.B. Saunders.
19 Arnell, K., S. Hill, J. Hart, et al. 2013. Persistent regurgitation in four dogs with caudal esophageal neoplasia. J Am Anim Hosp Assoc 49:58–63.
20 Arnold, E.J., M.O. Childress, L.M. Fourez, et al. 2011. Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 25:1385–1390.
21 Aronsohn, M. 1985. Canine thymoma. Vet Clin North Am Small Anim Pract 15:755–767.
22 Aronsohn, M.G. and J.L. Carpenter. 1990. Distal extremity melanocytic nevi and malignant melanomas in dogs. J Am Anim Hosp Assoc 26:605–612.
23 Atwater, S.W., B.E. Powers, R.D. Park, et al. 1994. Thymoma in dogs: 23 cases (1980–1991). J Am Vet Med Assoc 205:1007–1013.
24 Avallone, G., P. Boracchi, D. Stefanello, et al. 2014. Canine perivascular wall tumors: High prognostic impact of site, depth, and completeness of margins. Vet Pathol 51:713–721.
25 Back, A.R., S.E. Schleis, O.A. Smrkovski, et al. 2015. Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. Vet Comp Oncol 13:398–408.
26 Bacon, N.J., W.S. Dernell, N. Ehrhart, et al. 2007. Evaluation of primary re‐excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999–2004). J Am Vet Med Assoc 230:548–554.
27 Bacon, N.J., N.P. Ehrhart, W.S. Dernell, et al. 2008. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999–2006). J Am Vet Med Assoc 232:1504–1510.
28 Bacon, N.J., R.L. Gilbert, D.E. Bostock, et al. 2003. Total ear canal ablation in the cat: Indications, morbidity and long‐term survival. J Small Anim Pract 44:430–434.
29 Baez, J.L., M.J. Hendrick, F.S. Shofer, et al. 2004. Liposarcomas in dogs: 56 cases (1989–2000). J Am Vet Med Assoc 224:887–891.
30 Baginski, H., G. Davis, and R.P. Bastian. 2014. The prognostic value of lymph node metastasis with grade 2 Mcts in dogs: 55 cases (2001–2010). J Am Anim Hosp Assoc 50:89–95.
31 Banks, T.A., V. Langova, and R.C. Straw. 2003a. Repair of three pathological fractures in a dog with multiple myeloma. Aust Vet Pract 33:98–102.
32 Banks, T.A. and R.C. Straw. 2003. Canine soft tissue sarcomas: Incomplete resection treated with opla‐pt sponges. In. Australian Veterinary Associatoion Annual Conference, Science Week, Australian College of Veterinary Scientists, Surgery Chapter. Gold Coast, Queensland.
33 Banks, T.A., R.C. Straw, M. Thomson, et al. 2004. Soft tissue sarcoma in dogs: A study assessing surgical margin, tumor grade and clinical outcome. Aust Vet Pract 34:158–163.
34 Banks, T.A., R.C. Straw, S.J. Withrow, et al. 2003b. Prospective study of canine soft tissue sarcoma treated by wide surgical excision: Quantitative evaluation of surgical margins. In The 23rd Annual Conference of the Veterinary Cancer Society, Madison, WI, p. 21.
35 Bannink, E.O., M.L. Sauerbrey, M.N. Mullins, et al. 2008. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999–2006). J Am Vet Med Assoc 233:446–451.
36 Barber, L.G., K.U. Sorenmo, K.L. Cronin, et al. 2000. Combined doxorubicin and cyclophosphamide chemotherapy for nonresectable feline fibrosarcoma. J Am Anim Hosp Assoc 36:416–421.
37 Barnard, R.A., L.A. Wittenburg, R.K. Amaravadi, et al. 2014. Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma. Autophagy 10:1415–1425.
38 Barnard, S.M., R.M. Zuber, and A.S. Moore. 2007. Samarium Sm 153 lexidronam for the palliative treatment of dogs with primary bone tumors: 35 cases (1999–2005). J Am Vet Med Assoc 230:1877–1881.
39 Barnes, D.C. and J.L. Demetriou. 2017. Surgical management of primary, metastatic and recurrent anal sac adenocarcinoma in the dog: 52 cases. J Small Anim Pract 58:263–268.
40 Basinger, R.R., C.A. Rawlings, J.A. Barsanti, et al. 1989. Urodynamic alterations associated with clinical prostatic diseases and prostatic surgery in 23 dogs. J Am Anim Hosp Assoc 25:385–392.
41 Bateman, K.E., P.A. Catton, P.W. Pennock, et al. 1994. 0‐7‐21 radiation therapy for the treatment of canine oral melanoma. J Vet Intern Med 8:267–272.
42 Batschinski, K., N.G. Dervisis, and B.E. Kitchell. 2014. Evaluation of ifosfamide salvage therapy for metastatic canine osteosarcoma. Vet Comp Oncol 12:249–257.
43 Bearss, J.J., F.Y. Schulman, and D. Carter. 2012. Histologic, immunohistochemical, and clinical features of 27 mammary tumors in 18 male dogs. Vet Pathol 49:602–607.
44 Beauvais, W., J.M. Cardwell, and D.C. Brodbelt. 2012. The effect of neutering on the risk of mammary tumours in dogs–a systematic review. J Small Anim Pract 53:314–322.
45 Beaver, L.M., G. Strottner, and M.K. Klein. 2010. Response rate after administration of a single dose of doxorubicin in dogs with B‐cell or T‐cell lymphoma: 41 cases (2006–2008). J Am Vet Med Assoc 237:1052–1055.
46 Bennett, P.F., D.B. Denicola, P. Bonney, et al. 2002. Canine anal sac adenocarcinomas: Clinical presentation and response to therapy. J Vet Intern Med 16:100–104.
47 Berg, J., M.C. Gebhardt, and W.M. Rand. 1997. Effect of timing of postoperative chemotherapy on survival of dogs with osteosarcoma. Cancer 79:1343–1350.
48 Berg, J., M.J. Weinstein, S.H. Schelling, et al. 1992. Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb‐sparing surgery: 22 cases (1987–1990). J Am Vet Med Assoc 200:2005–2008.
49 Berg, J., M.J. Weinstein, D.S. Springfield, et al. 1995. Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma. J Am Vet Med Assoc 206:1555–1560.
50 Bergman, P.J., M.A. Camps‐Palau, J.A. Mcknight, et al. 2003a. Development of a xenogeneic DNA vaccine program for canine malignant melanoma with prolongation of survival in dogs with locoregionally controlled stage II–II disease. In Proceedings of the 23rd Annual Conference of the Veterinary Cancer Society, Madison, WI, 23: 40.
51 Bergman, P.J., M.A. Camps‐Palau, J.A. Mcknight, et al. 2004. Phase I & IB trials of murine tyrosinase ± human GM‐Csf Dna vaccination